IDEAYA Biosciences (IDYA)
(Delayed Data from NSDQ)
$39.50 USD
+0.33 (0.84%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $39.47 -0.03 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.66 |
EPS Last Quarter | -0.68 |
Last EPS Surprise | -23.64% |
ABR | 1.08 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.51 |
Next Year | -3.02 |
EPS (TTM) | -2.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.87M | 9.11M | 15.83M | 32.52M |
# of Estimates | 5 | 6 | 6 | 4 |
High Estimate | 8.33M | 16.67M | 25.00M | 64.68M |
Low Estimate | 5.00M | 6.00M | 7.00M | 20.00M |
Year ago Sales | 8.04M | 3.92M | 23.39M | 15.83M |
Year over Year Growth Est. | -14.60% | 132.42% | -32.29% | 105.39% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.66 | -0.65 | -2.51 | -3.02 |
# of Estimates | 7 | 7 | 7 | 7 |
Most Recent Consensus | -0.66 | -0.65 | -2.46 | -3.31 |
High Estimate | -0.55 | -0.47 | -2.22 | -2.41 |
Low Estimate | -0.77 | -0.75 | -2.70 | -3.57 |
Year ago EPS | -0.46 | -0.52 | -1.96 | -2.51 |
Year over Year Growth Est. | -43.48% | -25.00% | -28.06% | -20.43% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 6 | 6 | 6 | 6 |
Down Last 60 Days | 6 | 4 | 5 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.66 | -0.65 | -2.51 | -3.02 |
7 Days Ago | -0.66 | -0.65 | -2.51 | -3.02 |
30 Days Ago | -0.55 | -0.59 | -2.22 | -2.70 |
60 Days Ago | -0.59 | -0.62 | -2.37 | -2.79 |
90 Days Ago | -0.59 | -0.62 | -2.37 | -2.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.66 | -0.65 | -2.51 | -3.02 |
Zacks Consensus Estimate | -0.66 | -0.65 | -2.51 | -3.02 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.68 | -0.53 | -0.52 | -0.46 | NA |
Estimate | -0.55 | -0.53 | -0.49 | -0.47 | NA |
Difference | -0.13 | 0.00 | -0.03 | 0.01 | -0.04 |
Surprise | -23.64% | 0.00% | -6.12% | 2.13% | -6.91% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more